Cary Street Partners Investment Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cary Street Partners Investment Advisory's AMGN Position: Q2 2026 in Review
Cary Street Partners Investment Advisory reduced its Amgen (AMGN) stake by 9.4% in Q2 2026, selling an estimated $77.4K and leaving 2,175 shares worth $787K. The position accounts for 0.16% of the portfolio, ranked #140.
Cary Street Partners Investment Advisory first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.95M in Q3 2024. 1,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cary Street Partners Investment Advisory held 2,175 shares of Amgen worth $787K as of Q2 2026.
- Cary Street Partners Investment Advisory sold 226 Amgen shares in Q2 2026, an estimated $77.4K.
- Amgen made up 0.16% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #140 holding.
- Cary Street Partners Investment Advisory first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Cary Street Partners Investment Advisory's Amgen position peaked at $3.95M in Q3 2024.
- 1,785 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.